Skip to main content
Clinical Trials/DRKS00016614
DRKS00016614
Recruiting
Phase 2

Cardiac Magnetic Resonance for the PREdiction and DIagnostiCs of hearT failure - CMRPREDICT

Institut für Biomedizinische Technik (IBT) der Universität und ETH Zürich0 sites50 target enrollmentApril 11, 2019

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
I50.1
Sponsor
Institut für Biomedizinische Technik (IBT) der Universität und ETH Zürich
Enrollment
50
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 11, 2019
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Institut für Biomedizinische Technik (IBT) der Universität und ETH Zürich

Eligibility Criteria

Inclusion Criteria

  • Age of 18 years or older; signed Informed Consent Form; previously diagnosed heart failure. In a first, preliminary part of the study (pilot study, N \= 5\), also adults without cardiac pathologies will be enrolled.

Exclusion Criteria

  • Medically unstable or acute conditions; severe claustrophobia; known or suspected allergy to Gadovist or other Gadolinium based contrast agents; moderate or worse renal insufficiency; atrioventricular block of higher degree; allergic asthma bronchiale; diabetes mellitus; implants contraindicated at 1\.5T or 3\.0T; pregnancy; lactation; other physical/mental/linguistic conditions incompatible with the study protocol.

Outcomes

Primary Outcomes

Not specified

Similar Trials